S100P enhances the chemosensitivity of human gastric cancer cell lines

Cancer Biomarkers

Volumn 13, Issue 1, 2013, Pages 1-10

  Zhao, Xiaomu ^a   Bai, Zhigang ^a   Wu, Ping ^a   Zhang, Zhongtao ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

chemosensitivity; gastric cancer; oxaliplatin; S100P

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; OXALIPLATIN; S100P PROTEIN; SMALL INTERFERING RNA; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PLASMID; PRIORITY JOURNAL; STOMACH CANCER; SURVIVAL RATE; TUMOR GENE;

ANTINEOPLASTIC AGENTS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; ORGANOPLATINUM COMPOUNDS; P-GLYCOPROTEIN; RNA, MESSENGER; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFECTION;

EID: 84878923158     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130330     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005), 74-108.
2. Jemal A, Siegel R, Ward E,Hao Y, Xu J, Thun MJ. Cancer statistics,2009. CA Cancer J Clin 59 (2009), 225-49.
3. Inoue M, Tsugane S. Epidemiology of gastric cancer in Japan. Postgrad Med J 81 (2005), 419-24.
4. Becker T, Gerke V, Kube E,Weber K. S100P, a novel Ca (2+)-binding protein from human placenta. cDNA cloning, recombinant protein expression and Ca2+ binding properties. Eur J Biochem 207 (1992), 541-7.
5. Schor AP, Carvalho FM, Kemp C, Silva ID, Russo J. S100P calcium-binding protein expression is associated with highrisk proliferative lesions of the breast. Oncol Rep 15 (2006), 3-6.
6. Wang G, Platt-Higgins A, Carroll J, de Silva Rudland S,Winstanley J, Barraclough R, Rudland PS.Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res 66 (2006), 1199-207.
7. Dowen SE, Crnogorac-Jurcevic T, Gangeswaran R, Hansen M, Eloranta JJ, Bhakta V, Brentnall TA, Lütges J, Klöpel G, Lemoine NR. Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am J Pathol 166 (2005), 81-92.
8. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, Misek DE, Kuick R, Hanash S. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res. 2003 May 15;63(10): 2649-57.
9. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 63 (2003), 2649-57.
10. Mousses S, Bubendorf L,Wagner U, Hostetter G, Kononen J, Cornelison R, Goldberger N, Elkahloun AG,Willi N, Koivisto P, Ferhle W, Raffeld M, Sauter G, Kallioniemi OP. Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res 62 (2002), 1256-60.
11. Hammacher A, Thompson EW,Williams ED. Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgenrefractory and metastatic prostate cancer. Int J Biochem Cell Biol 37 (2005), 442-50.
12. Kita H, Hikichi Y, Hikami K, Tsuneyama K, Cui ZG, Osawa H, Ohnishi H, Mutoh H, Hoshino H, Bowlus CL, Yamamoto H, Sugano K. Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis. J Gastroenterol 41 (2006), 1053-63.
13. Birkenkamp-Demtroder K, Olesen SH, Søensen FB, Laurberg S, Laiho P, Aaltonen LA, Orntoft TF.Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 54 (2005), 374-84.
14. Bertram J, Palfner K, Hiddemann W, Kneba M. Elevated expression of S100P, CAPL and MAGE 3 in doxorubicinresistant cell lines: comparison of mRNA differential display reverse transcription-polymerase chain reaction and subtractive suppressive hybridization for the analysis of differential gene expression. Anticancer Drugs 9 (1998), 311-7.
15. Jia SQ, Niu ZJ, Zhang LH, Zhong XY, Shi T, Du H, Zhang GG, Hu Y, Su XL, Ji JF. Identification of prognosis-related proteins in advanced gastric cancer by mass spectrometrybased comparative proteomics. J Cancer Res Clin Oncol 135 (2009), 403-411.
16. Wang Q, He Z, Gao J, Hu S, Huang M, Liu M, Zheng J, Tang H. S100P sensitizes ovarian cancer cells to carboplatin and paclitaxel in vitro. Cancer Lett 272 (2008), 277-284.
17. Zhao XM, Bai ZG, Ma XM, Zhang ZT, Shi XY. Impact of S100P expression on clinical outcomes of gastric cancer patients with adjuvant chemotherapy of oxaliplatin and its mechanisms. Zhonghua Wai Ke Za Zhi 48 (2010), 1004-8.
18. Surowiak P, Maciejczyk A, Materna V, Drag-Zalesínska M, Wojnar A, Pudelko M, Kedzia W, Spaczýnski M, Dietel M, Zabel M, Lage H. Unfavourable prognostic significance of S100P expression in ovarian cancers. Histopathology 51 (2007), 125-8.
19. Arumugam T, Simeone DM, van Golen K, Logsdon CD. S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 11 (2005), 5356-64.
20. Basu GD, Azorsa DO, Kiefer JA, Rojas AM, Tuzmen S, Barrett MT, Trent JM, Kallioniemi O, Mousses S. Functional evidence implicating S100P in prostate cancer progression. Int J Cancer 123 (2008), 330-9.
21. Kang HC, Kim IJ, Park JH, et al. Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res 10 (2004), 272-284.
22. Tang H, Liu YJ, LiuM, Li X. Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/LOHP. Anticancer Drugs 18 (2007), 633-9.
23. Villeneuve DJ, Hembruff SL, Veitch Z, Cecchetto M, Dew WA, Parissenti AM. cDNA microarray analysis of isogenic paclitaxel-and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance. Breast Cancer Res Treat 96 (2006), 17-39.
24. He Z, Gao J, Wang Q, Liu M, Li Y, Li X, Tang H, Zheng J.S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3. Oncol Rep 20 (2008), 325-32.
25. Jastrzebska B, Filipek A, Nowicka D, Kaczmarek L, Kuznicki J. Calcyclin (S100A6) binding protein (CacyBP) is highly expressed in brain neurons. J Histochem Cytochem 48 (2000), 1195-202.
26. Ning X, Sun S, Hong L, Liang J, Liu L, Han S, Liu Z, Shi Y, Li Y, Gong W, Zhang S, Chen Y, Guo X, Cheng Y, Wu K, Fan D.Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Mol Cancer Res 5 (2007), 1254-1262.
27. Whiteman HJ, Weeks ME, Dowen SE, Barry S, Timms JF, Lemoine NR, Crnogorac-Jurcevic T.The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res 67 (2007), 8633-42.
28. Parkkila S, Pan PW, Ward A, Gibadulinova A, Oveckova I, Pastorekova S, Pastorek J, Martinez AR, Helin HO, Isola J. the calciun-binding protein S100P in normal and malignant human tissues. BMC Clin Pathol 8 (2008), 2.
29. Caruso ML, Valentini AM, Armentano R, Pirrelli M. P-170 glycoprotein expression in gastric and colorectal carcinomas and normal mucosa. An immunocytochemical study. In Vivo 9 (1995), 133-8.